Literature DB >> 21741600

miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis.

Avital Gaziel-Sovran1, Miguel F Segura, Raffaella Di Micco, Mary K Collins, Douglas Hanniford, Eleazar Vega-Saenz de Miera, John F Rakus, John F Dankert, Shulian Shang, Robert S Kerbel, Nina Bhardwaj, Yongzhao Shao, Farbod Darvishian, Jiri Zavadil, Adrian Erlebacher, Lara K Mahal, Iman Osman, Eva Hernando.   

Abstract

To metastasize, a tumor cell must acquire abilities such as the capacity to colonize new tissue and evade immune surveillance. Recent evidence suggests that microRNAs can promote the evolution of malignant behaviors by regulating multiple targets. We performed a microRNA analysis of human melanoma, a highly invasive cancer, and found that miR-30b/30d upregulation correlates with stage, metastatic potential, shorter time to recurrence, and reduced overall survival. Ectopic expression of miR-30b/30d promoted the metastatic behavior of melanoma cells by directly targeting the GalNAc transferase GALNT7, resulted in increased synthesis of the immunosuppressive cytokine IL-10, and reduced immune cell activation and recruitment. These data support a key role of miR-30b/30d and GalNAc transferases in metastasis, by simultaneously promoting cellular invasion and immunosuppression.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21741600      PMCID: PMC3681522          DOI: 10.1016/j.ccr.2011.05.027

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  47 in total

Review 1.  Cancer-associated mucins and mucin-type glycoproteins.

Authors:  V P Bhavanandan
Journal:  Glycobiology       Date:  1991-11       Impact factor: 4.313

Review 2.  Glycoprotein glycosylation and cancer progression.

Authors:  J W Dennis; M Granovsky; C E Warren
Journal:  Biochim Biophys Acta       Date:  1999-12-06

3.  Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells.

Authors:  F Yu; H Deng; H Yao; Q Liu; F Su; E Song
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

4.  8q24 amplification in transitional cell carcinoma of bladder.

Authors:  Harri Visapää; David Seligson; Mervi Eeva; Flora Gaber; JianYu Rao; Arie Belldegrun; Aarno Palotie
Journal:  Appl Immunohistochem Mol Morphol       Date:  2003-03

5.  Expression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: immunohistological evaluation using monoclonal antibodies to three members of the GalNAc-transferase family.

Authors:  U Mandel; H Hassan; M H Therkildsen; J Rygaard; M H Jakobsen; B R Juhl; E Dabelsteen; H Clausen
Journal:  Glycobiology       Date:  1999-01       Impact factor: 4.313

6.  Immunologic escape and angiogenesis in human malignant melanoma.

Authors:  Pedro Redondo; Ignacio Sánchez-Carpintero; Ana Bauzá; Michel Idoate; Teresa Solano; Martin C Mihm
Journal:  J Am Acad Dermatol       Date:  2003-08       Impact factor: 11.527

7.  Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function.

Authors:  Guido Serini; Donatella Valdembri; Sara Zanivan; Giulia Morterra; Constanze Burkhardt; Francesca Caccavari; Luca Zammataro; Luca Primo; Luca Tamagnone; Malcolm Logan; Marc Tessier-Lavigne; Masahiko Taniguchi; Andreas W Püschel; Federico Bussolino
Journal:  Nature       Date:  2003-07-24       Impact factor: 49.962

Review 8.  All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases.

Authors:  Kelly G Ten Hagen; Timothy A Fritz; Lawrence A Tabak
Journal:  Glycobiology       Date:  2002-11-01       Impact factor: 4.313

9.  DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications.

Authors:  C Van Den Berg; X Y Guan; D Von Hoff; R Jenkins; C Griffin; O Kallioniemi; J Herath
Journal:  Clin Cancer Res       Date:  1995-01       Impact factor: 12.531

Review 10.  Twinfilin, a molecular mailman for actin monomers.

Authors:  Sandra Palmgren; Maria Vartiainen; Pekka Lappalainen
Journal:  J Cell Sci       Date:  2002-03-01       Impact factor: 5.285

View more
  159 in total

1.  Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.

Authors:  Nathaniel H Fleming; Judy Zhong; Inês Pires da Silva; Eleazar Vega-Saenz de Miera; Bobbi Brady; Sung Won Han; Doug Hanniford; Jinhua Wang; Richard L Shapiro; Eva Hernando; Iman Osman
Journal:  Cancer       Date:  2014-08-25       Impact factor: 6.860

Review 2.  Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.

Authors:  Seema Chugh; Vinayaga S Gnanapragassam; Maneesh Jain; Satyanarayana Rachagani; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Biochim Biophys Acta       Date:  2015-08-28

Review 3.  Epigenetic biomarkers in skin cancer.

Authors:  Edward S Greenberg; Kelly K Chong; Kelly T Huynh; Ryo Tanaka; Dave S B Hoon
Journal:  Cancer Lett       Date:  2012-01-27       Impact factor: 8.679

Review 4.  Pivotal MicroRNAs in Melanoma: A Mini-Review.

Authors:  Zhenjun Deng; Jingang Hao; Dongyun Lei; Yongjing He; Lechun Lu; Li He
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

5.  De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium.

Authors:  Kirstine Lavrsen; Sally Dabelsteen; Sergey Y Vakhrushev; Asha M R Levann; Amalie Dahl Haue; August Dylander; Ulla Mandel; Lars Hansen; Morten Frödin; Eric P Bennett; Hans H Wandall
Journal:  J Biol Chem       Date:  2017-11-29       Impact factor: 5.157

Review 6.  The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.

Authors:  Muhammad Nauman Aftab; Marcel E Dinger; Ranjan J Perera
Journal:  Arch Biochem Biophys       Date:  2014-07-24       Impact factor: 4.013

7.  MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion.

Authors:  Jessica Bockhorn; Kathy Yee; Ya-Fang Chang; Aleix Prat; Dezheng Huo; Chika Nwachukwu; Rachel Dalton; Simo Huang; Kaitlin E Swanson; Charles M Perou; Olufunmilayo I Olopade; Michael F Clarke; Geoffrey L Greene; Huiping Liu
Journal:  Breast Cancer Res Treat       Date:  2012-12-07       Impact factor: 4.872

8.  Restoration of miR17/20a in solid tumor cells enhances the natural killer cell antitumor activity by targeting Mekk2.

Authors:  Hong Jiang; Ping Wang; Xiaohua Li; Qilong Wang; Zhong-Bin Deng; Xiaoying Zhuang; Jingyao Mu; Lifeng Zhang; Baomei Wang; Jun Yan; Donald Miller; Huang-Ge Zhang
Journal:  Cancer Immunol Res       Date:  2014-05-06       Impact factor: 11.151

9.  Insights into miRNA regulation of the human glycome.

Authors:  Brian T Kasper; Sujeethraj Koppolu; Lara K Mahal
Journal:  Biochem Biophys Res Commun       Date:  2014-01-23       Impact factor: 3.575

10.  MicroRNAs miR-30b, miR-30d, and miR-494 regulate human endometrial receptivity.

Authors:  Signe Altmäe; Jose A Martinez-Conejero; Francisco J Esteban; Maria Ruiz-Alonso; Anneli Stavreus-Evers; Jose A Horcajadas; Andres Salumets
Journal:  Reprod Sci       Date:  2012-08-17       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.